Biocardia logo

Biocardia share price today

(BCDA)

Biocardia share price is $1.97 & ₹167.40 as on 21 Dec 2024, 2.30 'hrs' IST

$1.97

0.13

(7.07%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Biocardia share price in Dollar and Rupees. Guide to invest in Biocardia from India. Also see the sentimental analysis on Indian investors investing in Biocardia. Get details on the Indian mutual funds that are investing in Biocardia. Get Analyst recommendations and forecasts along with all the Biocardia's financials.

Biocardia share price movements

  • Today's Low: $1.88
    Today's High: $2.06

    Day's Volatility :8.89%

  • 52 Weeks Low: $1.63
    52 Weeks High: $10.79

    52 Weeks Volatility :84.94%

Biocardia Returns

PeriodBiocardia IncIndex (Russel 2000)
3 Months
-20.24%
0.0%
6 Months
-30.39%
0.0%
1 Year
-79.79%
0.0%
3 Years
-94.14%
-19.7%

Biocardia Key Statistics

in dollars & INR

Previous Close
$1.84
Open
$1.93
Today's High
$2.0634
Today's Low
$1.88
Market Capitalization
$8.4M
Today's Volume
$51.5K
52 Week High
$10.7895
52 Week Low
$1.625
Revenue TTM
$428.0K
EBITDA
$-8.5M
Earnings Per Share (EPS)
$-4.03
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-703.62%

How to invest in Biocardia from India?

It is very easy for Indian residents to invest directly in Biocardia from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Biocardia stock in both Indian Rupees (INR) and US Dollars (USD). Search for Biocardia or BCDA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Biocardia or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Biocardia shares which would translate to 0.431 fractional shares of Biocardia as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Biocardia, in just a few clicks!

Returns in Biocardia for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Biocardia investment value today

Current value as on today

₹1,81,991

Returns

₹81,991

(+81.99%)

Returns from Biocardia Stock

₹79,795 (false-79.79%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Biocardia

42%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Biocardia on INDmoney from India has grown in the last 30 days as on Dec 21, 2024. 42% more investors are searching Biocardia in the last 30 days versus the previous period.

Global Institutional Holdings in Biocardia

  • Susquehanna International Group, LLP

    1.54%

  • Geode Capital Management, LLC

    0.32%

  • Vanguard Group Inc

    0.28%

  • Tower Research Capital LLC

    0.03%

  • Pingora Partners LLC

    0.02%

  • Bank of America Corp

    0.01%

Analyst Recommendation on Biocardia

Buy

    75%Buy

    25%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Biocardia(by analysts ranked 0 to 5 stars)

Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
2
2
3
Sell
0
0
0

Analyst Forecast on Biocardia

What analysts predicted

Upside of 1169.04%

Current:

$1.97

Target:

$25.00

Insights on Biocardia

  • Price Movement

    In the last 1 year, BCDA stock has moved down by -79.8%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 55.0K → 3.0K (in $), with an average decrease of 94.6% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -1.64M → -1.73M (in $), with an average decrease of 5.5% per quarter
  • BCDA vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 35.5% return, outperforming this stock by 115.3%
  • BCDA vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 23.0% return, outperforming this stock by 116.8%
  • Price to Sales

    ForBCDA every $1 of sales, investors are willing to pay $7.5, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.9 for every $1 of sales.

Biocardia Technicals Summary

Sell

Neutral

Buy

Biocardia is currently in a neutral trading position according to technical analysis indicators.

Biocardia Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Biocardia Inc
-7.73%
-30.39%
-79.79%
-94.14%
-96.44%
Regeneron Pharmaceuticals, Inc.
-5.73%
-34.03%
-17.11%
13.66%
87.56%
Biontech Se
4.48%
30.56%
7.36%
-56.46%
225.6%
Alnylam Pharmaceuticals, Inc.
-0.55%
10.11%
28.49%
30.99%
109.19%
Vertex Pharmaceuticals Incorporated
-11.79%
-16.36%
-1.97%
78.33%
80.59%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Biocardia Inc
NA
NA
0.0
-3.52
-7.04
-1.16
NA
-1.02
Regeneron Pharmaceuticals, Inc.
17.51
17.51
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.17
0.55
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Biocardia Inc
Buy
$8.4M
-96.44%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$77.8B
87.56%
17.51
33.61%
Biontech Se
Buy
$26.7B
225.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.8B
109.19%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$102.1B
80.59%
32.84
-4.51%

About Biocardia

we are a clinical-stage regenerative medicine company developing novel therapeutics for cardiovascular diseases with large unmet medical needs. biocardia is developing proprietary comprehensive biotherapeutic solutions for cardiovascular disease in its cardiamp™ and cardiallo™ therapies. clinical results supporting both therapeutic programs are compelling and build upon the most rigorous data in the field to date with intramyocardial delivery of marrow-derived cells. these programs are enabled by the company's helix™ transendocardial delivery systems and morph® vascular access products, which are partnered to enable other promising biotherapeutic programs.
Organization
Biocardia
Employees
16
CEO
Dr. Peter A. Altman Ph.D.
Industry
Biotechnology

Management People of Biocardia

NameTitle
Dr. Peter A. Altman Ph.D.
CEO, President & Director
Mr. David McClung
Chief Financial Officer
Mr. Edward M. Gillis
Senior Vice President of Devices

Important FAQs about investing in Biocardia from India :

What is Biocardia share price today?

Biocardia share price today stands at $1.97, Open: $1.93 ; Previous Close: $1.84 ; High: $2.06 ; Low: $1.88 ; 52 Week High: $10.79 ; 52 Week Low: $1.63. The stock opens at $1.93, after a previous close of $1.84. The stock reached a daily high of $2.06 and a low of $1.88, with a 52-week high of $10.79 and a 52-week low of $1.63.

Can Indians buy Biocardia shares?

Yes, Indians can invest in the Biocardia (BCDA) from India.

With INDmoney, you can buy Biocardia at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Biocardia at zero transaction cost.

How can I buy Biocardia shares from India?

It is very easy to buy Biocardia from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Biocardia be purchased?

Yes, you can buy fractional shares of Biocardia with INDmoney app.

What are the documents required to start investing in Biocardia stocks?

To start investing in Biocardia, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Biocardia

Today’s highest price of Biocardia (BCDA) is $2.06.

Today’s lowest price of Biocardia (BCDA) is $1.88.

What is today's market capitalisation of Biocardia

Today's market capitalisation of Biocardia BCDA is 8.4M

What is the 52 Week High and Low Range of Biocardia

  • 52 Week High

    $10.79

  • 52 Week Low

    $1.63

What are the historical returns of Biocardia?

  • 1 Month Returns

    -7.73%

  • 3 Months Returns

    -30.39%

  • 1 Year Returns

    -79.79%

  • 5 Years Returns

    -96.44%

Who is the Chief Executive Officer (CEO) of Biocardia

Dr. Peter A. Altman Ph.D. is the current Chief Executive Officer (CEO) of Biocardia.